SS Innovations International?(NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka
TipRanks (Fri, 11-Sep 12:00 PM ET)
SS Innovations Provides Update on Continuing Progress and Milestones
Globe Newswire (Thu, 10-Sep 8:30 AM ET)
SS Innovations Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 13-Aug 8:30 AM ET)
SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
Globe Newswire (Fri, 17-Jul 8:30 AM ET)
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer
Globe Newswire (Tue, 14-Jul 8:30 AM ET)
SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class
Globe Newswire (Tue, 7-Jul 8:30 AM ET)
IBN Initiates Coverage of SS Innovations International, Inc.
Globe Newswire (Tue, 7-Jul 8:30 AM ET)
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
Globe Newswire (Tue, 30-Jun 9:22 AM ET)
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
SS Innovations Intl trades on the NASDAQ stock market under the symbol SSII.
As of September 16, 2026, SSII stock price declined to $3.27 with 79,393 million shares trading.
SSII has a beta of 1.29, meaning it tends to be more sensitive to market movements. SSII has a correlation of 0.04 to the broad based SPY ETF.
SSII has a market cap of $655.26 million. This is considered a Small Cap stock.
Last quarter SS Innovations Intl reported $14 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $2 million and met earnings estimates .
The top ETF exchange traded funds that SSII belongs to (by Net Assets): ISMD, EWX.
SSII has underperformed the market in the last year with a price return of -39.4% while the SPY ETF gained +15.2%. SSII has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.1% and -2.1%, respectively, while the SPY returned +0.1% and -1.0%, respectively.
SSII support price is $3.15 and resistance is $3.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SSII shares will trade within this expected range on the day.